Novadaq Technologies (NVDQ) Earning Somewhat Positive Press Coverage, Report Shows
Press coverage about Novadaq Technologies (NASDAQ:NVDQ) (TSE:NDQ) has been trending somewhat positive on Thursday, according to Accern. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Novadaq Technologies earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 45.6678753880611 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the news headlines that may have effected Accern’s scoring:
- Buy or Hold? A Look at What the Technicals Are Saying About Novadaq Technologies Inc (NVDQ) – Sparta Review (spartareview.com)
- Volume Moving the Tape For Shares of Novadaq Technologies Inc (NVDQ) and Uniqure NV (QURE) – Evergreen Caller (evergreencaller.com)
- Head to Head Survey: Novadaq Technologies (NVDQ) & NxStage Medical (NXTM) (americanbankingnews.com)
- Novadaq Technologies, Inc. breached its 50 day moving average in a Bullish Manner : NVDQ-US : August 29, 2017 (finance.yahoo.com)
- Head to Head Survey: NxStage Medical (NXTM) vs. Novadaq Technologies (NVDQ) (americanbankingnews.com)
NVDQ has been the subject of a number of research analyst reports. Scotiabank reiterated an “outperform” rating and issued a $18.00 target price on shares of Novadaq Technologies in a research note on Thursday, May 4th. Zacks Investment Research upgraded shares of Novadaq Technologies from a “sell” rating to a “hold” rating in a research note on Tuesday, May 9th. Stifel Nicolaus reiterated a “buy” rating and issued a $10.00 target price on shares of Novadaq Technologies in a research note on Friday, June 2nd. Craig Hallum cut shares of Novadaq Technologies from a “buy” rating to a “hold” rating and set a $11.75 target price for the company. in a research note on Monday, June 19th. Finally, Canaccord Genuity cut shares of Novadaq Technologies from a “buy” rating to a “hold” rating and set a $11.75 target price for the company. in a research note on Monday, July 10th. One investment analyst has rated the stock with a sell rating, thirteen have given a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $11.86.
Shares of Novadaq Technologies (NASDAQ NVDQ) opened at 11.74 on Thursday. The firm’s 50 day moving average is $11.68 and its 200 day moving average is $8.79. Novadaq Technologies has a 12 month low of $5.84 and a 12 month high of $12.74. The company’s market cap is $678.83 million.
COPYRIGHT VIOLATION WARNING: This piece was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/31/novadaq-technologies-nvdq-earning-somewhat-positive-press-coverage-report-shows.html.
Novadaq Technologies Company Profile
NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.
Receive News & Stock Ratings for Novadaq Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc and related stocks with our FREE daily email newsletter.